1. Home
  2. ORIC
  3. ORIC News

Latest Oric Pharmaceuticals Inc. (ORIC) News on November 17, 2024

ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates
ORIC

GlobeNewswire

5 days ago

ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
ORIC

GlobeNewswire

13 days ago

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC

GlobeNewswire

16 days ago

ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC

MT Newswires

17 days ago

JonesTrading Initiates ORIC Pharmaceuticals at Buy With $17 Price Target

ORIC

MT Newswires

17 days ago

Wells Fargo Initiates ORIC Pharmaceuticals at Overweight With $20 Price Target

ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
ORIC

GlobeNewswire

25 days ago

ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Companies Like ORIC Pharmaceuticals (NASDAQ:ORIC) Are In A Position To Invest In Growth
ORIC

Simply Wall St.

a month ago

Companies Like ORIC Pharmaceuticals (NASDAQ:ORIC) Are In A Position To Invest In Growth

ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
ORIC

GlobeNewswire

a month ago

ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC

GlobeNewswire

a month ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC

MT Newswires

2 months ago

ORIC Pharmaceuticals Enters Discovery Collaboration With OpenBench

ORIC Pharmaceuticals, Inc. (ORIC): Short Seller Sentiment is Bearish on This Cancer Stock
ORIC

Insider Monkey

2 months ago

ORIC Pharmaceuticals, Inc. (ORIC): Short Seller Sentiment is Bearish on This Cancer Stock

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC

GlobeNewswire

2 months ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC

MT Newswires

2 months ago

Stifel Nicolaus Initiates Coverage on ORIC Pharmaceuticals With Buy Rating, $20 Price Target

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
ORIC

GlobeNewswire

3 months ago

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

ORIC

MT Newswires

3 months ago

Oppenheimer Adjusts ORIC Pharmaceuticals Price Target to $15 From $17, Maintains Outperform Rating

ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates
ORIC

GlobeNewswire

3 months ago

ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates

ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs
ORIC

GlobeNewswire

3 months ago

ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC

GlobeNewswire

3 months ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals (ORIC) Up on Collaboration With Bayer & JNJ
ORIC

Zacks

4 months ago

ORIC Pharmaceuticals (ORIC) Up on Collaboration With Bayer & JNJ

ORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners to Support Ongoing Trial Evaluating ORIC-944 in Combination with AR Inhibitors for the Treatment of Prostate Cancer
ORIC

GlobeNewswire

4 months ago

ORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners to Support Ongoing Trial Evaluating ORIC-944 in Combination with AR Inhibitors for the Treatment of Prostate Cancer

Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
ORIC

GlobeNewswire

4 months ago

Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors

Why Is ORIC Pharmaceuticals, Inc. (ORIC) Among the Most Shorted Stocks That Are Loved by Analysts?
ORIC

Insider Monkey

4 months ago

Why Is ORIC Pharmaceuticals, Inc. (ORIC) Among the Most Shorted Stocks That Are Loved by Analysts?

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC

GlobeNewswire

4 months ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC

GlobeNewswire

5 months ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
ORIC

GlobeNewswire

6 months ago

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth
ORIC

Simply Wall St.

6 months ago

We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth

ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
ORIC

GlobeNewswire

6 months ago

ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC

GlobeNewswire

6 months ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
ORIC

GlobeNewswire

7 months ago

ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC

ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
ORIC

GlobeNewswire

7 months ago

ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC

GlobeNewswire

7 months ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
ORIC

GlobeNewswire

7 months ago

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

How Much Upside is Left in Oric Pharmaceuticals (ORIC)? Wall Street Analysts Think 39.3%
ORIC

Zacks

8 months ago

How Much Upside is Left in Oric Pharmaceuticals (ORIC)? Wall Street Analysts Think 39.3%

ORIC

GuruFocus.com

8 months ago

ORIC Pharmaceuticals Inc (ORIC) Reports Q4 and Full Year 2023 Financial Results

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
ORIC

GlobeNewswire

8 months ago

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates

ORIC Pharmaceuticals Inc CEO Jacob Chacko Sells 40,000 Shares
ORIC

GuruFocus.com

8 months ago

ORIC Pharmaceuticals Inc CEO Jacob Chacko Sells 40,000 Shares

ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
ORIC

GlobeNewswire

8 months ago

ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference

ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
ORIC

GlobeNewswire

8 months ago

ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC

GlobeNewswire

9 months ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit
ORIC

GlobeNewswire

9 months ago

ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit

ORIC Pharmaceuticals CEO Jacob Chacko Sells 40,000 Shares
ORIC

GuruFocus.com

9 months ago

ORIC Pharmaceuticals CEO Jacob Chacko Sells 40,000 Shares

Recent Price Trend in Oric Pharmaceuticals, Inc. (ORIC) is Your Friend, Here's Why
ORIC

Zacks

9 months ago

Recent Price Trend in Oric Pharmaceuticals, Inc. (ORIC) is Your Friend, Here's Why

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC

GlobeNewswire

9 months ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Andreas Halvorsen's Viking Global Investors LP Acquires New Stake in ORIC Pharmaceuticals Inc
ORIC

GuruFocus.com

10 months ago

Andreas Halvorsen's Viking Global Investors LP Acquires New Stake in ORIC Pharmaceuticals Inc

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
ORIC

GlobeNewswire

10 months ago

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

IHOP launches pancake of the month deal
ORIC

Restaurant Dive

10 months ago

IHOP launches pancake of the month deal

Tesla, Colgate-Palmolive, BrightSpring Health: Top Stocks
ORIC

Yahoo Finance Video

10 months ago

Tesla, Colgate-Palmolive, BrightSpring Health: Top Stocks

In Bad News for IPO Market, BrightSpring Closes Below Offering Price
ORIC

The Wall Street Journal

10 months ago

In Bad News for IPO Market, BrightSpring Closes Below Offering Price

The First of Long Island (FLIC) Matches Q4 Earnings Estimates
ORIC

Zacks

10 months ago

The First of Long Island (FLIC) Matches Q4 Earnings Estimates

ORIC

Associated Press Finance

10 months ago

Closing prices for crude oil, gold and other commodities

7 EV Stocks to Turn $100,000 Into $1 Million: January 2024
ORIC

InvestorPlace

10 months ago

7 EV Stocks to Turn $100,000 Into $1 Million: January 2024

ORIC

Reuters

10 months ago

UPDATE 1-UK to return looted royal regalia to Ghana in loan deal

Here's Why Kinross Gold (KGC) is a Strong Value Stock
ORIC

Zacks

10 months ago

Here's Why Kinross Gold (KGC) is a Strong Value Stock

E2open Ocean Shipping Index Reflects Increase in Cross-Ocean Shipment Transit Times Due to Geopolitical Unrest and Natural Disasters
ORIC

Business Wire

10 months ago

E2open Ocean Shipping Index Reflects Increase in Cross-Ocean Shipment Transit Times Due to Geopolitical Unrest and Natural Disasters

Partnership with Evolv Technology a Slam Dunk for Houston’s Toyota Center
ORIC

Business Wire

10 months ago

Partnership with Evolv Technology a Slam Dunk for Houston’s Toyota Center

Amalgamated Financial Corp. Declares Regular Quarterly Dividend
ORIC

GlobeNewswire

10 months ago

Amalgamated Financial Corp. Declares Regular Quarterly Dividend

4 Silver Mining Stocks to Watch Amid Industry Challenges
ORIC

Zacks

10 months ago

4 Silver Mining Stocks to Watch Amid Industry Challenges

IGI to Release Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
ORIC

Business Wire

10 months ago

IGI to Release Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

Oric Pharmaceuticals, Inc. (ORIC) Is a Great Choice for 'Trend' Investors, Here's Why
ORIC

Zacks

10 months ago

Oric Pharmaceuticals, Inc. (ORIC) Is a Great Choice for 'Trend' Investors, Here's Why

Target Hospitality Announces Senior Level Promotions
ORIC

PR Newswire

10 months ago

Target Hospitality Announces Senior Level Promotions

Trump-Tied SPAC Surges 175% in Six-Day Rally
ORIC

Bloomberg

10 months ago

Trump-Tied SPAC Surges 175% in Six-Day Rally

ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
ORIC

GlobeNewswire

10 months ago

ORIC Pharmaceuticals Announces $125 Million Private Placement Financing

Ecovyst Provides Update on Plans for Expansion of Orange, Texas, Catalyst Activation Facility
ORIC

PR Newswire

10 months ago

Ecovyst Provides Update on Plans for Expansion of Orange, Texas, Catalyst Activation Facility

Genco Highlights Steps the Company Is Taking to Drive Sustainable, Long-Term Shareholder Value
ORIC

GlobeNewswire

10 months ago

Genco Highlights Steps the Company Is Taking to Drive Sustainable, Long-Term Shareholder Value

Eaton Vance Tax Advgd Gbl Div Inc Fd's Dividend Analysis
ORIC

GuruFocus.com

10 months ago

Eaton Vance Tax Advgd Gbl Div Inc Fd's Dividend Analysis

Eaton Vance Enhanced Equity Income Fund II's Dividend Analysis
ORIC

GuruFocus.com

10 months ago

Eaton Vance Enhanced Equity Income Fund II's Dividend Analysis

Unpacking Q3 Earnings: Hormel Foods (NYSE:HRL) In The Context Of Other Packaged Food Stocks
ORIC

StockStory

10 months ago

Unpacking Q3 Earnings: Hormel Foods (NYSE:HRL) In The Context Of Other Packaged Food Stocks

Schnitzer Steel Industries (NASDAQ:RDUS) Is Due To Pay A Dividend Of $0.1875
ORIC

Simply Wall St.

10 months ago

Schnitzer Steel Industries (NASDAQ:RDUS) Is Due To Pay A Dividend Of $0.1875

Bill Appleton retiring as Scripps' chief legal officer; Dave Giles appointed to succeed him
ORIC

PR Newswire

10 months ago

Bill Appleton retiring as Scripps' chief legal officer; Dave Giles appointed to succeed him

Enerflex Ltd. Provides Full-Year 2023 Update and Preliminary Outlook for 2024
ORIC

GlobeNewswire

10 months ago

Enerflex Ltd. Provides Full-Year 2023 Update and Preliminary Outlook for 2024

3 Stocks to Buy for Value and Growth
ORIC

Zacks

10 months ago

3 Stocks to Buy for Value and Growth

ChipMOS REPORTS 22.2% YoY INCREASE IN 4Q23 REVENUE AND 21.1% YoY INCREASE IN DECEMBER 2023 REVENUE
ORIC

PR Newswire

10 months ago

ChipMOS REPORTS 22.2% YoY INCREASE IN 4Q23 REVENUE AND 21.1% YoY INCREASE IN DECEMBER 2023 REVENUE

Final Boarding Call: 3 Stocks Set for a Sky-High Surge
ORIC

InvestorPlace

10 months ago

Final Boarding Call: 3 Stocks Set for a Sky-High Surge

ORIC Pharmaceuticals Provides Initial Phase 1b Data for ORIC-944, Operational Highlights for 2023, and Anticipated Upcoming Milestones
ORIC

GlobeNewswire

10 months ago

ORIC Pharmaceuticals Provides Initial Phase 1b Data for ORIC-944, Operational Highlights for 2023, and Anticipated Upcoming Milestones

Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate
ORIC

GlobeNewswire

10 months ago

Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate

OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ORIC

GlobeNewswire

10 months ago

OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Kura Sushi USA, Inc. (NASDAQ:KRUS) Q1 2024 Earnings Call Transcript
ORIC

Insider Monkey

10 months ago

Kura Sushi USA, Inc. (NASDAQ:KRUS) Q1 2024 Earnings Call Transcript

Radius Health, Inc. (NASDAQ:RDUS) Q1 2024 Earnings Call Transcript
ORIC

Insider Monkey

10 months ago

Radius Health, Inc. (NASDAQ:RDUS) Q1 2024 Earnings Call Transcript

Xencor (XNCR) Soars 6.0%: Is Further Upside Left in the Stock?
ORIC

Zacks

10 months ago

Xencor (XNCR) Soars 6.0%: Is Further Upside Left in the Stock?

PIMCO Closed-End Funds Declare Monthly Common Share Distributions
ORIC

GlobeNewswire

10 months ago

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Alpha and Omega Semiconductor to Participate in the 26th Annual Needham Growth Conference on January 17, 2024 in New York City
ORIC

Business Wire

10 months ago

Alpha and Omega Semiconductor to Participate in the 26th Annual Needham Growth Conference on January 17, 2024 in New York City

ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ORIC

GlobeNewswire

10 months ago

ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Cyberattacks Might Soon Cost Businesses $10.5 Trillion Every Year -- 2 Cybersecurity Growth Stocks to Buy in 2024
ORIC

Motley Fool

a year ago

Cyberattacks Might Soon Cost Businesses $10.5 Trillion Every Year -- 2 Cybersecurity Growth Stocks to Buy in 2024

Director, 10% Owner James Sanfilippo Sells Shares of John B Sanfilippo & Son Inc
ORIC

GuruFocus.com

a year ago

Director, 10% Owner James Sanfilippo Sells Shares of John B Sanfilippo & Son Inc

ORIC

Business Wire

a year ago

Empire State Realty Trust Announces Stock Repurchase Authorization

3 Hidden-Gem Penny Growth Stocks With 1,000% Upside
ORIC

InvestorPlace

a year ago

3 Hidden-Gem Penny Growth Stocks With 1,000% Upside

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORIC

GlobeNewswire

a year ago

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 Exciting Small Cap Stocks with Dividend Yields Over 5%
ORIC

Zacks

a year ago

3 Exciting Small Cap Stocks with Dividend Yields Over 5%

MFA Financial, Inc. Announces Dividend of $0.35 per Share
ORIC

Business Wire

a year ago

MFA Financial, Inc. Announces Dividend of $0.35 per Share

Zscaler, Inc. (ZS) Hits Fresh High: Is There Still Room to Run?
ORIC

Zacks

a year ago

Zscaler, Inc. (ZS) Hits Fresh High: Is There Still Room to Run?

JIN MEDICAL INTERNATIONAL LTD. Empowers "Lao Le Hui" Assisted Bathing Project with Portable Nano-thermal Therapy Bath
ORIC

GlobeNewswire

a year ago

JIN MEDICAL INTERNATIONAL LTD. Empowers "Lao Le Hui" Assisted Bathing Project with Portable Nano-thermal Therapy Bath

JIN MEDICAL INTERNATIONAL LTD. Secures RMB66 Million in Orders for Innovative Micro-Hyperbaric Oxygen Chamber Equipment
ORIC

GlobeNewswire

a year ago

JIN MEDICAL INTERNATIONAL LTD. Secures RMB66 Million in Orders for Innovative Micro-Hyperbaric Oxygen Chamber Equipment

With 54% ownership of the shares, Enerflex Ltd. (TSE:EFX) is heavily dominated by institutional owners
ORIC

Simply Wall St.

a year ago

With 54% ownership of the shares, Enerflex Ltd. (TSE:EFX) is heavily dominated by institutional owners

Why Is PRA Group (PRAA) Up 21.6% Since Last Earnings Report?
ORIC

Zacks

a year ago

Why Is PRA Group (PRAA) Up 21.6% Since Last Earnings Report?

Fresh Del Monte: A Cheap but Cyclical Stock
ORIC

GuruFocus.com

a year ago

Fresh Del Monte: A Cheap but Cyclical Stock

Investors in MannKind (NASDAQ:MNKD) have seen solid returns of 115% over the past five years
ORIC

Simply Wall St.

a year ago

Investors in MannKind (NASDAQ:MNKD) have seen solid returns of 115% over the past five years

Has AMERISAFE, Inc. (NASDAQ:AMSF) Stock's Recent Performance Got Anything to Do With Its Financial Health?
ORIC

Simply Wall St.

a year ago

Has AMERISAFE, Inc. (NASDAQ:AMSF) Stock's Recent Performance Got Anything to Do With Its Financial Health?

ProPetro Appoints Chief Commercial Officer and Chief Accounting Officer
ORIC

Business Wire

a year ago

ProPetro Appoints Chief Commercial Officer and Chief Accounting Officer

Warren Buffett and Corporate Insiders Love These Stocks
ORIC

Insider Monkey

a year ago

Warren Buffett and Corporate Insiders Love These Stocks

Shenandoah Telecommunications Company (NASDAQ:SHEN) is favoured by institutional owners who hold 62% of the company
ORIC

Simply Wall St.

a year ago

Shenandoah Telecommunications Company (NASDAQ:SHEN) is favoured by institutional owners who hold 62% of the company

Share on Social Networks: